The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Open accessAbstract
Acute myocardial infarction (MI) due to coronary artery occlusion is accompanied by a pathological remodeling response that includes hypertrophic cardiac growth and fibrosis, which impair cardiac contractility. Previously, we showed that cardiac hypertrophy and heart failure are accompanied by characteristic changes in the expression of a collection of specific microRNAs (miRNAs), which act as negative regulators of gene expression. Here, we show that MI in mice and humans also results in the dysregulation of specific miRNAs, which are similar to but distinct from those involved in hypertrophy and heart failure. Among the MI-regulated miRNAs are members of the miR-29 family, which are down-regulated in the region of the heart adjacent to the infarct. The miR-29 family targets a cadre of mRNAs that encode proteins involved in fibrosis, including multiple collagens, fibrillins, and elastin. Thus, down-regulation of miR-29 would be predicted to derepress the expression of these mRNAs and enhance the fibrotic response. Indeed, down-regulation of miR-29 with anti-miRs in vitro and in vivo induces the expression of collagens, whereas over-expression of miR-29 in fibroblasts reduces collagen expression. We conclude that miR-29 acts as a regulator of cardiac fibrosis and represents a potential therapeutic target for tissue fibrosis in general.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 1×
“To further explore the potential role of miR-29 as a negative regulator of collagen expression, we knocked down miR-29b in vivo, using cholesterol-modified oligonucleotides (21, 22) complementary to the mature miRNA sequence of miR-29b (antimiR-29b) and either saline or an oligonucleotide containing a four base mismat…”
MethodTransforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., Richardson, J. A., & Olson, E. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608791103 · Cited by 1,507
Self-citationMolecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Phylogenetic Shadowing and Computational Identification of Human microRNA Genes
Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H. A., & Cuppen, E. (2005) · Cell · doi:10.1016/j.cell.2004.12.031 · Cited by 1,270 · cited 1×
“There are estimated to be as many as 1,000 miRNAs encoded by the human genome (16).”
BackgroundMicroRNA Pathways in Flies and Worms
Ambros, V. (2003) · Cell · doi:10.1016/s0092-8674(03)00428-8 · Cited by 1,217
Cited by
Items 101–138 of 138
Kumarswamy, R., Volkmann, I., Jazbutyte, V., Dangwal, S., Park, D.-H., & Thum, T. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.234286 · Cited by 293
Diabetes Complications: The MicroRNA Perspective
Kantharidis, P., Wang, B., Carew, R. M., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db11-0082 · Cited by 289
Treating Disease at the RNA Level with Oligonucleotides
Levin, A. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1705346 · Cited by 287
miRNAs as serum biomarkers for Duchenne muscular dystrophy
Cacchiarelli, D., Legnini, I., Martone, J., Cazzella, V., D'Amico, A., Bertini, E., & Bozzoni, I. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100133 · Cited by 279
Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
Hu, M. C., Shi, M., Cho, H. J., Adams-Huet, B., Paek, J., Hill, K., Shelton, J., Amaral, A. P., Faul, C., Taniguchi, M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050465 · Cited by 278
Self-citationGallant-Behm, C. L., Piper, J., Lynch, J. M., Seto, A. G., Hong, S. J., Mustoe, T. A., Maari, C., Pestano, L. A., Dalby, C. M., Jackson, A. L., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.11.007 · Cited by 278
Self-citationTargeting TGF-β signaling for the treatment of fibrosis
Györfi, A. H., Matei, A.-E., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 274
Zhang, Y., Huang, X.-R., Wei, L.-H., Chung, A. C., Yu, C.-M., & Lan, H.-Y. (2014) · Molecular Therapy · doi:10.1038/mt.2014.25 · Cited by 271
RetractedEllison, G. M., Waring, C. D., Vicinanza, C., & Torella, D. (2012) · Heart · doi:10.1136/heartjnl-2011-300639 · Cited by 268
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Divakaran, V., & Mann, D. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.183087 · Cited by 267
Karakikes, I., Chaanine, A. H., Kang, S., Mukete, B. N., Jeong, D., Zhang, S., Hajjar, R. J., & Lebeche, D. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000078 · Cited by 266
Micro RNA‐24 regulates cardiac fibrosis after myocardial infarction
Wang, J., Huang, W., Xu, R., Nie, Y., Cao, X., Meng, J., Xu, X., Hu, S., & Zheng, Z. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01523.x · Cited by 266
Long, J., Wang, Y., Wang, W., Chang, B. H. J., & Danesh, F. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194969 · Cited by 266
A Systematic Review of miR-29 in Cancer
Kwon, J. J., Factora, T. D., Dey, S., & Kota, J. (2019) · Molecular Therapy Oncolytics · doi:10.1016/j.omto.2018.12.011 · Cited by 263
Zhao, Y., Cao, J., Melamed, A., Worley, M., Gockley, A., Jones, D., Nia, H. T., Zhang, Y., Stylianopoulos, T., Kumar, A. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818357116 · Cited by 259
MicroRNAs and the regulation of fibrosis
Jiang, X., Tsitsiou, E., Herrick, S. E., & Lindsay, M. A. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07632.x · Cited by 258
MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease
Olson, E. N. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009008 · Cited by 255
Self-citationGreco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., Cardani, R., Perbellini, R., Isaia, E., Sale, P., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-128579 · Cited by 253
MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation
Dawson, K., Wakili, R., Ördög, B., Clauss, S., Chen, Y., Iwasaki, Y., Voigt, N., Qi, X. Y., Sinner, M. F., Dobrev, D., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001207 · Cited by 252
Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T., & Satoh, J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01076.x · Cited by 245
MicroRNA therapeutics in cardiovascular medicine
Thum, T. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100191 · Cited by 193
Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma
Gerber, E. E., Gallo, E. M., Fontana, S. C., Davis, E. C., Wigley, F. M., Huso, D. L., & Dietz, H. C. (2013) · Nature · doi:10.1038/nature12614 · Cited by 190
MicroRNAs and cardiovascular diseases
Ono, K., Kuwabara, Y., & Han, J. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08090.x · Cited by 169
Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research
Witwer, K. W., & Halushka, M. K. (2016) · RNA Biology · doi:10.1080/15476286.2016.1236172 · Cited by 151
miR-196a Downregulation Increases the Expression of Type I and III Collagens in Keloid Fibroblasts
Kashiyama, K., Mitsutake, N., Matsuse, M., Ogi, T., Saenko, V. A., Ujifuku, K., Utani, A., Hirano, A., & Yamashita, S. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.22 · Cited by 139
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis
Chioccioli, M., Roy, S., Newell, R., Pestano, L., Dickinson, B., Rigby, K., Herazo-Maya, J., Jenkins, G., Ian, S., Saini, G., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104304 · Cited by 129
McManus, D. D., Tanriverdi, K., Lin, H., Esa, N., Kinno, M., Mandapati, D., Tam, S., Okike, O. N., Ellinor, P. T., Keaney, J. F., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2014.09.050 · Cited by 116
Coenzyme Q10: From bench to clinic in aging diseases, a translational review
Gutierrez-Mariscal, F. M., Yubero-Serrano, E. M., Villalba, J. M., & Lopez-Miranda, J. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1442316 · Cited by 92
“Various studies have shown a relationship between these extracellular matrix genes and expression of this microRNA-29 family (van Rooij et al., 2008).”
BackgroundYao, Z., Li, J., Xiong, H., Cui, H., Ning, J., Wang, S., Ouyang, X., Qian, Y., & Fan, C. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00906-4 · Cited by 84
Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells
Li, J., Zhang, Y., Kuruba, R., Gao, X., Gandhi, C. R., Xie, W., & Li, S. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.068247 · Cited by 78
“A study from van Rooij et al. (2008) has shown that dysregulation of miR-29 plays an important role in cardiac fibrosis after myocardial infarction.”
BackgroundAtheroprotective mechanisms of shear stress-regulated microRNAs
Boon, R. A., Hergenreider, E., & Dimmeler, S. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-07-0491 · Cited by 78
Wagner, V., Kern, F., Hahn, O., Schaum, N., Ludwig, N., Fehlmann, T., Engel, A., Henn, D., Rishik, S., Isakova, A., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01751-6 · Cited by 72
“19).”
Song, Y.-S., Joo, H.-W., Park, I.-H., Shen, G.-Y., Lee, Y., Shin, J. H., Kim, H., & Kim, K.-S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179972 · Cited by 53
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
“The Olson lab demonstrated that miR-29 is decreased after MI and that it targets ECM protein mRNAs, including collagens, fibrillin, and elastins (120).”
BackgroundNormalization strategy is critical for the outcome of miRNA expression analyses in the rat heart
Brattelid, T., Aarnes, E.-K., Helgeland, E., Guvaåg, S., Eichele, H., & Jonassen, A. K. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00131.2010 · Cited by 42
Mullenbrock, S., Liu, F., Szak, S., Hronowski, X., Gao, B., Juhasz, P., Sun, C., Liu, M., McLaughlin, H., Xiao, Q., et al. (2018) · Genes · doi:10.3390/genes9120588 · Cited by 35
Yu, X., Elfimova, N., Müller, M., Bachurski, D., Koitzsch, U., Drebber, U., Mahabir, E., Hansen, H. P., Friedman, S. L., Klein, S., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.013 · Cited by 27
Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium
Mount, S., Kanda, P., Parent, S., Khan, S., Michie, C., Davila, L., Chan, V., Davies, R. A., Haddad, H., Courtman, D., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1418-3 · Cited by 12
Metadata
- Authors
- van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13027-13032
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2155290141
- Cited by
- 1,844
- References
- 32
- FWCI
- 53.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.